Drug Profile
H 447
Alternative Names: EMD-82633; H447; MAb H-447; MDX-447Latest Information Update: 14 Jun 2004
Price :
$50
*
At a glance
- Originator IDM S.A.
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Epidermal growth factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Head and neck cancer; Renal cancer; Solid tumours
Most Recent Events
- 14 Jun 2004 No development reported - Phase-I for Renal cancer in USA (unspecified route)
- 14 Jun 2004 No development reported - Phase-II for Head and neck cancer in USA (IV)
- 14 Jun 2004 No development reported - Phase-II for Solid tumours in USA (IV)